Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 or 9.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested
Appears in 3 contracts
Samples: Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc), Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty payment obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK’s licenses to Merck pursuant to Section 3.1 (other than Sections 3.1(a), 3.1(b3.1(e) and 3.2 as were in effect immediately prior to such expiration 3.1(f)) shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: License and Research Collaboration Agreement, License and Research Collaboration Agreement (Aveo Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 11.2 or 9.311.3, this Agreement shall continue in full force and effect until expiration of all royalty payment obligations hereunderunder Article 7 have been made by Merck or otherwise expired for all Licensed Products in the Territory (the “Term”). Upon expiration (but not early termination) of this Agreement and provided that all royalty obligations under this Agreementpayments hereunder have been made, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.), Exclusive License and Research Collaboration Agreement (Artiva Biotherapeutics, Inc.)
Term and Expiration. This Agreement shall be effective as of the ------------------- Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 7.2 or 9.37.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Article 2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: License Agreement (Cytrx Corp), License Agreement (Cytrx Corp)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Interneuron Pharmaceuticals Inc), Research Collaboration and License Agreement (Intercardia Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder Article 5. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: License and Research Collaboration Agreement (Aveo Pharmaceuticals Inc), License and Research Collaboration Agreement (Aveo Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Development and License Agreement (Isis Pharmaceuticals Inc), Development and License Agreement (Isis Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and and, unless terminated earlier pursuant to Section 9.2 under Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Celera CORP), Research Collaboration and License Agreement (Celera CORP)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder Article 5. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 2 contracts
Samples: Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of-this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Isis Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such (a) Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration under Article 3 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested; and (b) FHT’s license granted pursuant to Section 3.2.2, if in effect at such time, will become a perpetual, fully-paid up license.
Appears in 1 contract
Samples: Collaboration and License Agreement (Foxhollow Technologies, Inc.)
Term and Expiration. This Agreement shall be effective as of the Effective Closing Date and and, unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK's and DOV's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and Section 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Exclusive License, Development and Commercialization Agreement (Dov Pharmaceutical Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. licenses [*** Confidential Treatment Requested*].
Appears in 1 contract
Samples: Exclusive License and Research Collaboration Agreement (Proteostasis Therapeutics, Inc.)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty payment obligations hereunder. Upon expiration of this Agreement due to the expiration of all royalty obligations under this Agreementpayment obligations, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: License and Research Collaboration Agreement (Decode Genetics Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 13.3 or 9.313.4, this Agreement shall continue in full force and effect until expiration of all royalty payment (including sharing of US Adjusted Net Sales) obligations hereunderhereunder (the “Term”). Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 2.1.1 and 3.2 as were in effect immediately prior to such expiration 2.2.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requestedlicenses and Endocyte’s covenant in Section 2.2.2 shall continue until such time as Merck is no longer selling Product.
Appears in 1 contract
Samples: Collaboration, Exclusive License and Companion Diagnostic Agreement (Endocyte Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a)Section 3.1, 3.1(b) and 3.2 as were in effect immediately prior to such expiration if granted, shall become fully paid-up, perpetual licenses. *** Confidential Treatment RequestedFor the purposes of this Agreement, “
Appears in 1 contract
Samples: Exclusive License and Research Collaboration Agreement (Surmodics Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date Date, and unless terminated earlier pursuant to Section 9.2 8.2 or 9.3Section 8.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunderhereunder (the “Term”). Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment RequestedConfidential
Appears in 1 contract
Samples: License and Research Collaboration Agreement (Opko Health, Inc.)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Neogenesis Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and and, unless terminated earlier pursuant to Section 9.2 under Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder this Agreement. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreement, such licenses to Merck pursuant to Sections 3.1(a)Subsection 5.4.1, 3.1(b) and 3.2 as were in effect immediately prior MERCK’s licenses pursuant to such expiration Article III shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Arena Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.2.1 and 3.2 as were in effect immediately prior to such expiration 3.2.2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and Option to License Agreement (Armata Pharmaceuticals, Inc.)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become non-exclusive, fully paid-up, perpetual licenses. *** Confidential Treatment Requestedlicenses which shall be limited to the Field.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Nitromed Inc)
Term and Expiration. This Agreement shall be effective as of ------------------- the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 7.2 or 9.37.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Article 2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: License Agreement (Cytrx Corp)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty payment obligations hereunder. Upon expiration of this Agreement due to the expiration of all royalty obligations under this Agreementpayment obligations, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: License and Research Collaboration Agreement (Decode Genetics Inc)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such the licenses granted to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Exclusive Development, Commercialization and License Agreement (Nastech Pharmaceutical Co Inc)
Term and Expiration. 9.1.1 This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon natural expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research, Development and Commercialization License Agreement (Geron Corporation)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Exclusive License and Research Collaboration Agreement (Avalon Pharmaceuticals Inc)
Term and Expiration. This Agreement shall be become effective as of upon the Effective Date and unless and, if not otherwise terminated earlier pursuant to Section 9.2 or 9.3this Article 8, this Agreement shall continue in effect until expire upon the expiration of all royalty obligations hereunderhereunder for any Products related thereto. Upon expiration of all royalty obligations this Agreement under this AgreementSection 8.1, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and Section 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, irrevocable, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Bionomics Limited/Fi)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) 3.1.1 and 3.2 as were in effect immediately prior to such expiration 3.1.2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Exclusive License and Research Collaboration Agreement (Idera Pharmaceuticals, Inc.)
Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Licensed Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.2 and 3.2 as were in effect immediately prior to such expiration 3.3 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.
Appears in 1 contract
Samples: Research Collaboration and Exclusive License Agreement (Foghorn Therapeutics Inc.)